Busca avançada
Ano de início
Entree


Recombinant Human Peptide Growth Factors, Bone Morphogenetic Protein-7 (rhBMP7), and Platelet-Derived Growth Factor-BB (rhPDGF-BB) for Osteoporosis Treatment in an Oophorectomized Rat Model

Texto completo
Autor(es):
Reis, Thamara Goncalves ; Del Colletto, Alice Marcela Sampaio ; Silva, Luiz Augusto Santana ; Koga, Bruna Andrade Aguiar ; Sogayar, Mari Cleide ; Carreira, Ana Claudia Oliveira
Número total de Autores: 6
Tipo de documento: Artigo Científico
Fonte: BIOMOLECULES; v. 14, n. 3, p. 19-pg., 2024-03-01.
Resumo

Bone morphogenetic protein (BMP) and platelet-derived growth factor (PDGF) are known to regulate/stimulate osteogenesis, playing vital roles in bone homeostasis, rendering them strong candidates for osteoporosis treatment. We evaluated the effects of recombinant human BMP-7 (rhBMP7) and PDGF-BB (rhPDGF-BB) in an oophorectomy-induced osteoporosis rat model. Forty Sprague Dawley rats underwent oophorectomy surgery; treatments commenced on the 100th day post-surgery when all animals exhibited signs of osteoporosis. These peptide growth factors were administered intraocularly (iv) once or twice a week and the animals were monitored for a total of five weeks. Two weeks after the conclusion of the treatments, the animals were euthanized and tissues were collected for assessment of alkaline phosphatase, X-ray, micro-CT, and histology. The results indicate that the most promising treatments were 20 mu g/kg rhPDGF-BB + 30 mu g/kg rhBMP-7 twice a week and 30 mu g/kg BMP-7 twice a week, showing significant increases of 15% (p < 0.05) and 13% (p < 0.05) in bone volume fraction and 21% (p < 0.05) and 23% (p < 0.05) in trabecular number, respectively. In conclusion, rhPDGF-BB and rhBMP-7 have demonstrated the ability to increase bone volume and density in this osteoporotic animal model, establishing them as potential candidates for osteoporosis treatment. (AU)

Processo FAPESP: 16/05311-2 - Medicina regenerativa visando à terapia de doenças crônico-degenerativas (câncer e diabetes)
Beneficiário:Mari Cleide Sogayar
Modalidade de apoio: Auxílio à Pesquisa - Temático